Top HIV scientist says he wouldn't count on a vaccine for coronavirus soon

A top U.S. scientist said on Wednesday that governments should not count on a successful vaccine against COVID-19 being developed anytime soon when deciding whether to ease restrictions imposed to curb the pandemic.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Health care is enjoying an abundance of positive attention as a result of the coronavirus pandemic. My question, my challenge, is how can we sustain this love-fest between the public and the health care profession even after we obtain a vaccine or an effective treatment for COVID-19? Let ’s be perfectly honest: six months ago, the […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - Category: General Medicine Authors: Tags: Physician COVID-19 coronavirus Infectious Disease Practice Management Source Type: blogs
Authors: Stefano ML, Kream RM, Stefano GB Abstract The emergence of the novel ß-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global pandemic of coronavirus disease 2019 (COVID-19). Clinical studies have documented that potentially severe neurological symptoms are associated with SARS-CoV-2 infection, thereby suggesting direct CNS penetration by the virus. Prior studies have demonstrated that the destructive neurological effects of rabies virus (RABV) infections are mediated by CNS transport of the virus tightly bound to the nicotinic acetylcholine receptor (nACh...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
(Natural News) People across the globe are experiencing unprecedented levels of stress and anxiety as they struggle to cope with the fallout from the COVID-19 pandemic. While hundreds of thousands are mourning the loss of friends and family, millions more are reeling from the economic devastation that has resulted from the strict lockdown measures instituted...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Thirty-seven countries and the World Health Organization (WHO) appealed on Friday for common ownership of vaccines, medicines and diagnostic tools to tackle the global coronavirus pandemic, taking aim at patent laws they fear could become a barrier to sharing crucial supplies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Ken Terry Paul Grundy By PAUL GRUNDY, MD and KEN TERRY Date: June 20, 2022. The Smithsonian National Museum of Natural History has reported its biggest number of visitors in more than 2 ½ years. There’s a string of new Broadway musicals that are well-attended every night. It’s safe to shop in malls, eat out in restaurants and go to movie theaters again. Of course, this has all been made possible by an effective vaccine against COVID-19 that was widely administered in the fall of 2021. Vaccinated citizens of the world are now confident that it’s safe to go out in public, albeit with a...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Medical Practice Primary Care Ken Terry Paul Grundy Source Type: blogs
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
CONCLUSIONS: This new disease is pushing the scientific community to develop swiftly a safe and effective vaccine. Notwithstanding the limitations of our analysis, given by the absence of available results, we try to provide a comprehensive view of the ongoing clinical trials in humans. Our analysis reveals a worldwide effort of both scientists and enterprises to achieve one of the most challenging goals of our century. PMID: 32456404 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
As the global prevalence of novel coronavirus 2019 (COVID-19) increases, with a death toll exceeding that during wartime, scientists and clinicians alike are racing against time to provide clarity on pathogenesis, mode of transmission, and to research potential treatment and vaccines amid the pandemic. In the meantime, hospital guidance1 is essential to protect health care providers (HCPs) and for disease containment. However, definitive guidelines are often elusive given the rapid emergence of new data and the time constraints for robust evidence.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Tags: Letter Source Type: research
State Department-backed Armenian project to promote democracy instead features false informationCoronavirus – latest updatesSee all our coronavirus coverageThe US government is funding a website inArmenia which is spreading disinformation about the coronavirus pandemic, including warnings that Armenians ought to “refuse” future vaccine programmes.The website, Medmedia.am, was launched with the help of a US State Department grant meant to promote democracy, but instead has been used to promote false information about Covid-19, according toan investigation bythe Britishnews website openDemocracy.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Armenia World news US news Coronavirus outbreak Science Vaccines and immunisation Source Type: news
As nations around the world scramble to bring coronavirus outbreaks under control, Dr. Raj Panjabi is worried that the world’s poor populations will be excluded from accessing treatments and prevention measures, a scenario he calls “viral apartheid.” “I don’t use that term lightly,” said Panjabi, speaking with TIME Senior Writer Alice Park during a TIME 100 Talks discussion on May 28. “The idea that a group of people—whether it’s the vaccines, the test or treatments—will get access to those vital life-saving tools, and that those will likely be the rich nations an...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news
More News: Coronavirus | COVID-19 | Health | Pandemics | Vaccines